Decision Makers
| Name (plus bio) |
Position |
| Donald E. Morel Jr. |
CEO |
| Patrick J. Zenner |
Interim CEO |
| Donald A. McMillan |
President, North America Pharmaceutical Systems Division |
| Robert C. Young |
President, Fox Chase Cancer Center |
| Robert Keating |
President, Europe and Asia Pacific |
| Steven A. Ellers |
President, Pharmaceutical Systems Division |
| Bill O'Dell |
Vice President, Sales, Marketing |
| Fran DeGrazio |
Vice President, Marketing & Strategic Business Development |
| Jeffrey McGuire |
Vice President, Business Development Drug Delivery Division |
| John Gailey |
General Counsel and Secretary & Vice President |
| Joseph Abbott |
Vice President |
| Linda Altemus |
Vice President |
| Michael Anderson |
Vice President |
| Richard Luzzi |
Vice President, Human Resources |
| Debbie Thomas |
Director, Regulatory Affairs |
| Dominick J. Labresco |
Director, Corp Real Estate |
| Nancy Cressman |
Director, Global Communications |
| Anthony Welters |
Director |
| Geoffrey F. Worden |
Director |
| Jenne K. Britell |
Director |
| John H. Weiland |
Director |
| John P Neafsey |
Director |
| Lance Willsey |
Director |
| Tenley E. Albright |
Director |
| William H. Longfield |
Director |
Board of Directors
Age 50
Director since 2002
Dr. Morel has been Chairman of the Board of the Company since March 2003 and Chief Executive Officer since April 2002. He was President from April 2002 to June 2005, Chief Operating Officer from May 2001 to April 2002, Division President, Drug Delivery Systems from October 1999 to May 2001, and prior thereto, Group President.
Age 61
Director since 2002
Mr. Zenner is the retired President and Chief Executive Officer of Hoffmann-La Roche Inc., a pharmaceutical manufacturer. Mr. Zenner currently serves as the Interim Chief Executive Officer and a member of the Board of Directors of EXACT Sciences Corporation. He also is a director of ArQule, Inc., CuraGen Corporation, Geron Corporation, Sciele Pharma, Inc. and Xoma Ltd.
| Organization |
Position |
Status |
| West Pharmaceutical Services, Inc. |
Interim CEO |
Current |
| 454 Life Sciences Corporation |
|
Current |
| ArQule, Inc. |
Chairman |
Current |
| CuraGen Corporation |
Chairman |
Current |
| Fairleigh Dickinson University |
Chairman of the Board |
Current |
| EXACT Sciences Corporation |
Chairman |
Current |
| Genta Incorporated |
Director |
Current |
| ArQule, Inc. |
Board of Directors |
Current |
| Dendrite International, Inc. |
Director |
Current |
| Sciele Pharma, Inc. |
Director |
Current |
| Geron Corporation |
Board of Directors |
Current |
| XOMA Corporation |
Director |
Current |
| CuraGen Corporation |
Director |
Current |
| West Pharmaceutical Services, Inc. |
Director |
Current |
| EXACT Sciences Corporation |
Board of Directors |
Current |
| Creighton University |
Board of Directors |
Current |
| Fairleigh Dickinson University |
Board of Directors |
Current |
| Nextwave Pharmaceuticals, Inc. |
Director |
Current |
| PhRMA |
Member |
Current |
| Biotechnology Industry Organization |
Member |
Current |
| Hoffmann-La Roche Inc. |
CEO |
Former |
| EXACT Sciences Corporation |
Interim Chief Executive Officer |
Former |
| Hoffmann-La Roche Inc. |
President |
Former |
| Roche |
Senior Vice President |
Former |
| Roche Laboratories |
Vice President |
Former |
| Roche Laboratories |
General Manager |
Former |
| CuraGen Corporation |
Member of Compensation Committee |
Former |
| Roche Holding Ltd. |
head of international |
Former |
| Hoffmann-La Roche Inc. |
Sales Representative |
Former |
| Biotechnology Industry Organization |
Board Member |
Former |
| Healthcare Leadership Council |
Board Member |
Former |
| Fairleigh Dickinson University |
M.B.A. |
Former |
| Creighton University |
B.S.B.A. |
Former |
| Fairleigh Dickinson University |
BS In Business |
Former |
| ArQule, Inc. |
member |
Former |
| XOMA Corporation |
member |
Former |
| Organization |
Position |
Status |
| Fox Chase Cancer Center |
President |
Current |
| West Pharmaceutical Services, Inc. |
President, Fox Chase Cancer Center |
Current |
| NYSE Group, Inc. |
|
Current |
| National Cancer Institute |
Chairman, Board of Scientific Advisors |
Current |
| The National Comprehensive Cancer Network, Inc |
Chairman of the Board |
Current |
| American Cancer Society, Inc. |
Director |
Current |
| West Pharmaceutical Services, Inc. |
Director |
Current |
| Huntsman Cancer Institute and Co |
Board of Directors |
Current |
| Human Genome Sciences, Inc. |
Director |
Current |
| American Society of Clinical Oncology |
President |
Former |
| American Cancer Society, Inc. |
President |
Former |
| Huntsman Cancer Institute and Co |
President, Fox Chase Cancer Center, Philadelphia, Pennsylvania |
Former |
| National Cancer Institute |
Chief of the Medical Branch |
Former |
| NCI, Inc. |
|
Former |
| Weill Medical College of Cornell University |
M.D. |
Former |
| The Ohio State University |
B.Sc. degree in zoology |
Former |
In September 2007, Anthony Welters was named president of the Public and Senior Markets Group, which is made up of Ovations and AmeriChoice. He was appointed executive vice president, UnitedHealth Group, in December 2006. Welters had previously been president, chief executive officer and a founder of AmeriChoice, which was acquired by UnitedHealth Group in 2002. Prior to his role with AmeriChoice, Welters held a number of senior positions in the federal government and in private industry.
| Organization |
Position |
Status |
| UnitedHealth Group Incorporated |
President, Public and Senior Markets Group & Executive Vice President |
Current |
| C.R. Bard, Inc. |
Executive Vice President, United Health Group |
Current |
| New York University School of Medicine |
Trustee |
Current |
| NYSE Group, Inc. |
|
Current |
| AmeriChoice Corporation |
Chairman |
Current |
| Morehouse School of Medicine |
Chairman |
Current |
| New York University School of Medicine |
Board of Directors |
Current |
| C.R. Bard, Inc. |
Director |
Current |
| West Pharmaceutical Services, Inc. |
Director |
Current |
| Qwest Communications International Inc. |
Director |
Current |
| New York University |
Vice Chair |
Current |
| AmeriChoice Corporation |
Chief Executive Officer |
Former |
| AmeriChoice Corporation |
President |
Former |
| AmeriChoice Corporation |
Founder |
Former |
| Smithsonian Institution |
|
Former |
| New York University School of Law |
J.D |
Former |
| Manhattanville College |
Bachelors Degree |
Former |
Chairman of United Rentals and Chief Executive Officer of Structured Ventures; former Executive Officer of several General Electric financial services companies; also a Director of Quest Diagnostics and U.S. - Russia Investment Fund.
| Organization |
Position |
Status |
| Crown Holdings, Inc. |
Chief Executive Officer,Structured Ventures |
Current |
| Crown Holdings, Inc. |
Chairperson |
Current |
| West Pharmaceutical Services, Inc. |
Director |
Current |
| Quest Diagnostics Incorporated |
Board of Directors |
Current |
| Fox Chase Cancer Center |
Board of Directors |
Current |
| Lincolnjobs.Com |
Board of Directors |
Current |
| General Electric Capital Corporation |
CEO |
Former |
| General Electric Capital Corporation |
President |
Former |
| General Electric Capital Corporation |
senior executive |
Former |
| Republic New York Corporation |
|
Former |
| Aames Financial Corporation |
Director |
Former |
| Lincoln Financial Group |
Director |
Former |
| Lincoln Financial Group |
Board of Directors |
Former |
| Aames Investment Corporation |
Board of Directors |
Former |
| Crown Holdings, Inc. |
Director |
Former |
| Columbia University |
Ph.D. |
Former |
| Harvard University |
master's degree |
Former |
John H. Weiland, 51, joined C. R. Bard, Inc. on March 1, 1996. His experience spans over 30 years in the healthcare industry with firms such as Dentsply
International, Pharmacia and Baxter Healthcare Corporation.
John was named President and Chief Operating Officer of C. R. Bard on August 8, 2003, having worldwide responsibility for all of Bard's business operations.
Prior to becoming President and COO, John held the position of Group President of Bard. In this capacity, John had global responsibility for Bard Medical
Division, Bard Urological Division, Davol Inc., Bard Endoscopic Technologies Division and Bard's Worldwide Manufacturing Operations. In addition, John also
had responsibility for Bard's businesses in Latin America, Mexico, Canada, the Far East and Japan.
In 1991, he was named Senior Vice President North America Group for Dentsply International in York, Pennsylvania. This position included general management
responsibility for the eleven operating divisions of Dentsply International, the world's leading dental products manufacturer.
John graduated from DeSales University with a B.S. degree and earned an M.B.A. degree from New York University. John started his career at Baxter/American
Hospital Supply Corporation in 1977 as a sales representative. He rose through numerous managerial positions to become Vice President and General Manager of
the Scientific Products Biomedical Division, an 850 million dollar diagnostic division of Baxter. In 1989, he became President and Chief Executive Officer of
Pharmacia Diagnostics, a division of Pharmacia AB Upsala Sweden. In this capacity, he had general management responsibility for Pharmacia's three diagnostic
businesses.
In addition to his professional activities, John is actively involved in civic affairs. In 1987, John was named a White House Fellow and served as a Special
Assistant to President Reagan's Cabinet. He is a member of the Board of Directors of Meridian Health System and a Director of West Pharmaceutical Services,
Inc.
| Organization |
Position |
Status |
| Cornell University |
Presidential Counselor |
Current |
| Jn Associates |
President |
Current |
| Nes Rentals |
Lead Director |
Current |
| NYSE Group, Inc. |
|
Current |
| Constar International, Inc. |
Chairman |
Current |
| NES Rentals Holdings, Inc. |
Board Chairman |
Current |
| West Pharmaceutical Services, Inc. |
Chairman |
Current |
| Cornell University |
Board of Directors |
Current |
| Nes Rentals |
Director |
Current |
| Federal Home Loan Bank of Des Moines |
Director |
Current |
| Greenwich Capital Markets, Inc. |
CEO |
Former |
| Greenwich Capital Markets, Inc. |
President |
Former |
| Sun Company, Inc. |
chief financial officer |
Former |
| Sun Oil Company |
Chief Financial Officer |
Former |
| Helios Capital |
Chief Financial Officer |
Former |
| Sun Company, Inc. |
executive vice president |
Former |
| Helios Capital |
Executive Vice President |
Former |
| Sun Oil Company |
Executive Vice President for Canadian Operations |
Former |
| Cornell University |
Trustee Emeritus |
Former |
| Alliance Holdings GP, L.P. |
Chairman |
Former |
| Constar International, Inc. |
Board of Directors |
Former |
| West Pharmaceutical Services, Inc. |
Director |
Former |
| Greenwich Capital Markets, Inc. |
Board of Directors |
Former |
| Cornell University |
Master of Business Administration Degree |
Former |
| Cornell University |
Bachelor Degrees |
Former |
Age 66
Director since 1989
Mr. Johnson is Managing Partner of Founders Capital Partners, a venture capital angel group. He is Chairman of the Board of HealthBanks Inc. Mr. Johnson is a member of the Corporation of the Massachusetts Institute of Technology and a trustee of the Scholarship Foundation of Santa Barbara.
Lance Willsey, MD has served as a director since May 2000. Dr. Willsey was a founding partner of DCF Capital from July 1998 to April 2002. From July 1997 to July 1998, Dr. Willsey served on the Staff Department of Urologic Oncology at Dana Farber Cancer Institute at Harvard University School of Medicine. From July 1996 to July 1997, Dr. Willsey served on the Staff Department of Urology at Massachusetts General Hospital at Harvard University School of Medicine, where he was a urology resident from July 1992 to July 1996. Dr. Willsey is also a director of Exelixis, Inc. Dr. Willsey holds a BS in physiology from Michigan State University and an MS in biology and an MD from Wayne State University. Patrick J. Zenner has served as a director since March 2003. In January 2001, Mr. Zenner retired from Hoffmann-La Roche Inc., North America, the prescription drug unit of the Roche Group, a leading research-based health care enterprise, where he served as President and Chief Executive Officer since 1993, and was a member of the global Pharmaceutical Executive Committee. Mr. Zenner joined Hoffmann-La Roche Inc. as a sales representative in 1969 and subsequently held a series of marketing and business development posts that culminated in his being named Vice President and General Manager of Roche Laboratories in 1982. He later spent two and a half years with Roche Holding Ltd. as head of international pharmaceutical marketing, development and regulation. In 1988, Mr. Zenner was elected to Hoffmann-La Roche's Executive Committee and Board of Directors, and appointed Senior Vice President of the pharmaceutical division. Mr. Zenner also serves as a director of ArQule, Inc., Curagen Corporation, Dendrite International, Inc., First Horizon Pharmaceuticals Corporation, Genta Inc., Geron Corporation, Praecis Pharmaceuticals, Inc, West Pharmaceutical Services, Inc. and Xoma Ltd. Mr. Zenner holds a BS in business administration from Creighton University and an MBA from Fairleigh Dickinson University and is a Trustee of both universities.
| Organization |
Position |
Status |
| West Pharmaceutical Services, Inc. |
Director |
Current |
| ArQule, Inc. |
Director |
Current |
| EXACT Sciences Corporation |
Board of Directors |
Current |
| Geron Corporation |
Director |
Current |
| XOMA Corporation |
Director |
Current |
| CuraGen Corporation |
Director |
Current |
| Dendrite International, Inc. |
Director |
Current |
| Hoffmann-La Roche Inc. |
Board of Directors |
Current |
| Genta Incorporated |
Director |
Current |
| Exelixis, Inc. |
Board of Directors |
Current |
| Hoffmann-La Roche Inc. |
President and Chief Executive Officer |
Former |
| Hoffmann-La Roche Inc. |
Senior Vice President |
Former |
| Roche Laboratories |
Vice President and General Manager |
Former |
| Hoffmann-La Roche Inc. |
Sales Representative |
Former |
| Roche Holding Ltd. |
|
Former |
| Wayne State University |
MD |
Former |
| Wayne State University |
Ms In Biology and An Md |
Former |
| Fairleigh Dickinson University |
Mba |
Former |
| Creighton University |
Bs In Business Administration |
Former |
| Michigan State University |
BS In Physiology |
Former |
| Organization |
Position |
Status |
| Harvard Medical School |
Associate Professor |
Current |
| NYSE Group, Inc. |
|
Current |
| West Pharmaceutical Services, Inc. |
Board of Directors |
Current |
| Women's Health |
Executive Director |
Former |
| Women and Company |
|
Former |
| Organization |
Position |
Status |
| Harvard Medical School |
Lecturer |
Current |
| NYSE Group, Inc. |
|
Current |
| Westar Energy, Inc. |
Chairman |
Current |
| West Pharmaceutical Services, Inc. |
Director |
Current |
| Whitehead Institute for Biomedical Research |
Director |
Current |
| State Street Corporation |
Director |
Former |
| Radcliffe College |
Graduate |
Former |
| Harvard Medical School |
Graduate |
Former |
Mr. Federici joined Synvista's Board of Directors in October 2008. He joined West Pharmaceutical Services as Vice President and Chief Financial Officer in August of 2003. Under his financial leadership, West Pharmaceutical has grown its revenues from $300M to over $1B. He was previously National Industry Director for Pharmaceuticals of KPMG LLP (accounting firm) from June 2002 until August 2003, and prior thereto, an audit partner with Arthur Andersen, LLP.
Array
| Organization |
Position |
Status |
| NYSE Group, Inc. |
|
Current |
| Celera Diagnostics, LLC |
|
Current |
| Celera Genomics |
|
Current |
| Rozynski & Associates |
|
Current |
| Resgen Inc. |
Board of Directors |
Current |
| Pittsburgh Tissue Engineering Initiative, Inc |
Board of Directors |
Current |
| Olink |
Board of Directors |
Current |
| Ionsource, LLC |
Board of Directors |
Current |
| IDEXX Laboratories, Inc. |
Board of Directors |
Current |
| Industry Ventures |
Board of Directors |
Current |
| HCR ManorCare, Inc. |
Board of Directors |
Current |
| Applied Biosystems Group |
Board of Directors |
Current |
| Horizon Health Corporation |
Director |
Current |
| West Pharmaceutical Services, Inc. |
Director |
Current |
| Applera Corporation |
Director |
Current |
| C.R. Bard, Inc. |
Director |
Current |
| Microseq |
Board of Directors |
Current |
| Biolayer Corporation Limited |
Board of Directors |
Current |
| Centenary College |
Trustee |
Current |
| Healthios Group, LLC |
Member |
Current |
| C.R. Bard, Inc. |
President |
Former |
| Lifemark |
Officer |
Former |
| American Hospital Supply Corporation |
|
Former |
| Lifemark |
Director |
Former |
| Northwestern University |
Graduate Degree In Management |
Former |
| Drake University |
Bachelor's Degrees In Business Administration |
Former |
Executive News
-
West Pharmaceutical Services to Present at the 2009 UBS Global Specialty Pharmaceuticals Conference
Pharma Live - 6/03/09 - View Story
-
West Pharmaceutical Services to Present at the 2009 UBS Global Specialty Pharmaceuticals...
Reuters - 5/29/09 - View Story
-
West Pharmaceutical Services to Present at the 2009 UBS Global Specialty Pharmaceuticals Conference
PR Newswire - 5/29/09 - View Story
-
On the Boards
Philadelphia Inquirer - 5/11/09 - View Story